Beirne Wealth Consulting Services’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Buy
421,858
+10,000
+2% +$29.9K 0.26% 40
2026
Q1
$1.27M Buy
411,858
+35,400
+9% +$150K 0.36% 45
2025
Q4
$1.36M Sell
376,458
-34,000
-8% -$148K 0.39% 43
2025
Q3
$1.55M Buy
410,458
+68,000
+20% +$263K 0.37% 50
2025
Q2
$1.33M Buy
342,458
+48,000
+16% +$260K 0.43% 39
2025
Q1
$1.47M Hold
294,458
0.52% 34
2024
Q4
$2.12M Sell
294,458
-8,342
-3% -$63.7K 0.77% 29
2024
Q3
$1.86M Buy
302,800
+25,000
+9% +$169K 0.65% 29
2024
Q2
$1.85M Buy
277,800
+5,000
+2% +$36.9K 0.74% 29
2024
Q1
$2.78M Sell
272,800
-31,000
-10% -$315K 1.18% 23
2023
Q4
$3.42M Buy
303,800
+54,380
+22% +$227K 1.69% 13
2023
Q3
$880K Hold
249,420
0.7% 33
2023
Q2
$880K Hold
249,420
0.7% 33
2023
Q1
$1.05M Buy
249,420
+12,400
+5% +$147K 0.74% 27
2022
Q4
$3.9M Sell
237,020
-45,800
-16% -$514K 1.92% 11
2022
Q3
$3.61M Sell
282,820
-1,827
-0.6% -$27K 1.37% 13
2022
Q2
$3.33M Buy
284,647
+100,807
+55% +$622K 2.18% 10
2022
Q1
$1.12M Buy
183,840
+47,000
+34% +$346K 0.62% 37
2021
Q4
$1.25M Buy
136,840
+4,900
+4% +$52.1K 0.69% 26
2021
Q3
$1.49M Sell
131,940
-1,830
-1% -$22.3K 0.85% 25
2021
Q2
$1.32M Buy
133,770
+21,000
+19% +$287K 0.72% 28
2021
Q1
$1.59M Buy
112,770
+36,545
+48% +$591K 0.94% 24
2020
Q4
$860K Buy
+76,225
New +$898K 0.43% 47

Other funds holding ALT

Beirne Wealth Consulting Services's ALT Position: Q2 2026 in Review

Beirne Wealth Consulting Services increased its Altimmune (ALT) stake by 2.4% in Q2 2026, buying an estimated $29.9K and bringing the position to 421,858 shares worth $1.28M. The position accounts for 0.26% of the portfolio, ranked #40.

Beirne Wealth Consulting Services first reported a position in ALT in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.9M in Q4 2022. 38 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Beirne Wealth Consulting Services held 421,858 shares of Altimmune worth $1.28M as of Q2 2026.
  • Beirne Wealth Consulting Services bought 10,000 Altimmune shares in Q2 2026, an estimated $29.9K.
  • Altimmune made up 0.26% of Beirne Wealth Consulting Services's portfolio in Q2 2026, its #40 holding.
  • Beirne Wealth Consulting Services first reported a position in Altimmune in Q4 2020 and has held it in 23 quarters since.
  • Beirne Wealth Consulting Services's Altimmune position peaked at $3.9M in Q4 2022.
  • 38 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Beirne Wealth Consulting Services's 13F filing for Q2 2026, filed 15 Jul 2026.